(UroToday.com) At the 2021 International Kidney Cancer Symposium (IKCS): North America meeting, Dr. Brian Lane gave the Andrew C. Novick Award Lecture with a talk focusing on the management of T1 renal masses. In the context of understanding his career trajectory and his clinical and research interests, Dr. Lane began by highlighting the value of his […]
(UroToday.com) In the Top Abstracts session of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting, Dr. Khaleel presented their work examining outcomes for patients with metastatic renal cell carcinoma (mRCC) treated with initial cytoreductive nephrectomy followed by active surveillance. By way of background, Dr. Khalell highlighted that the role of cytoreductive nephrectomy is controversial […]
(UroToday.com) In the Top Abstracts session of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting, Dr. Kaushik presented work examining the role of glutamine metabolism in clear cell renal cell carcinoma (ccRCC).
(UroToday.com) The International Kidney Cancer Symposium 2021 annual hybrid meeting included a non-clear cell renal cell carcinoma (RCC) session and a presentation by Dr. Bradley McGregor discussing recent and future studies of systemic therapy for non-clear cell RCC. Dr. McGregor started by highlighting that non-clear cell RCC has worse outcomes than clear cell RCC. In a […]
(UroToday.com) In a session of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting focused on the role and effects of adjuvant immunotherapy in renal cell carcinoma (RCC) on subsequent first-line therapy, Dr. Choueiri provided an overview of his perspective of the future of adjuvant therapy in this disease space.
(UroToday.com) The International Kidney Cancer Symposium 2021 annual hybrid meeting included a non-clear cell renal cell carcinoma (RCC) session and a presentation by Dr. Saeed Hassanpour discussing the use of artificial intelligence deep learning in histologic classification for renal cell carcinoma (RCC). Dr. Hassanpour started by noting that RCC is the most common renal cancer […]
(UroToday.com) The International Kidney Cancer Symposium 2021 annual hybrid meeting included a non-clear cell renal cell carcinoma (RCC) session and a presentation by Dr. Ivan Pedrosa discussing phenotypic characterization of renal masses by a virtual biopsy approach. Dr. Pedrosa notes that many renal masses are found incidentally, typically by a single-phase ‘total body’ contrast-enhanced CT […]
(UroToday.com) The International Kidney Cancer Symposium 2021 annual hybrid meeting included a non-clear cell renal cell carcinoma (RCC) session and a presentation by Dr. Ronald Boris discussing surgical management of non-clear cell renal cell carcinoma (RCC). Dr. Boris notes that histology matters in the behavior of both local and advanced RCC. Histology may allow us […]
With the development of minimally invasive surgery technology, patients with bladder cancer are increasingly receiving laparoscopic radical cystectomy (LRC) or robotic-assisted radical cystectomy (RARC) treatment.
San Francisco, CA (UroToday.com) — A study from Washington University School of Medicine in St. Louis has identified an RNA molecule that suppresses prostate tumors. According to the research — conducted in mice implanted with human prostate tumor samples — restoring this so-called long noncoding RNA could be a new strategy to treat prostate cancer that […]
